Kohei Miyazono was born in Japan, in 1956, and received his M.D. degree at the University of Tokyo in 1981, and D.M.S. at the same university in 1988. He started to work at the Department of Hematology at the University of Tokyo, and then moved to Dr. Carl-Henrik Heldin`s lab in Uppsala, Sweden in 1985. After going back to Japan between 1988-1990, he moved to Sweden again, and became assistant and associate member at the Ludwig Institute for Cancer Research, Uppsala, Sweden (between 1990 and 1995). He returned to Japan, and became the Chief of the Department of Biochemistry, the Cancer Institute of Japanese Foundation for Cancer Research in 1995. In 2000, he was appointed to his current position as a full professor at the University of Tokyo. Kohei Miyazono received Incitement Award of the Japanese Cancer Association (1996), Erwin von Bälz Prize (1997), Honorary Doctor of Medicine of Uppsala University, Sweden (1999), Princess Takamatsu Cancer Research Award (2000), Academic Award of the Mochida Memorial Foundation (2003), Academic Award of the Inoue Foundation of Science (2006), Medical Award of the Japan Medical Association (2006), and the Takeda Foundation Award (2008). His research interest is mechanisms of action of the TGF-b family factors and their relation to development of cancer, mechanisms of angiogenesis and lymphangiogenesis, and studies on tumor suppressor genes.